Inventor · disambiguated record
Scott W. Rowlinson
Also filed as: ROWLINSON SCOTT W · ROWLINSON SCOTT WILLIAM
7 granted patents·10 pending applications·48 citations·filing 2002–2025
82Inventor score
Files withAERASE INC4LILLY CO ELI3AEGLEA BIOTHERAPEUTICS INC2IMMEDICA PHARMA AB2AEGLEA BIO THERAPEUTICS INC1
Top patents by PatentIndex Score
17 records- 0193US7494651B2TGF-β binding antibodiesLILLY CO ELI·Filed 2006·Granted Feb 24, 2009·27 cites·4 claims
- 0289US7927593B2TGF-beta binding antibodiesLILLY CO ELI·Filed 2010·Granted Apr 19, 2011·15 cites·10 claims
- 0382US11717562B2Method and composition for treating arginase 1 deficiencyAERASE INC·Filed 2018·Granted Aug 8, 2023·2 cites·46 claims
- 0479US10729752B2Compositions and methods for treating cancer with arginine depletion and immuno oncology agentsAERASE INC·Filed 2017·Granted Aug 4, 2020·2 cites·28 claims
- 0575US12331335B2Methods for production of human recombinant arginase 1 and uses thereofIMMEDICA PHARMA AB·Filed 2023·Granted Jun 17, 2025·0 cites·16 claims
- 0673US11466066B2Variants of human BMP7 proteinLILLY CO ELI·Filed 2018·Granted Oct 11, 2022·2 cites·16 claims
- 0768US2024009284A1Method and composition for treating arginase 1 deficiencyAERASE INC·Filed 2023·Application pending·0 cites
- 0867US2025346881A1Methods for production of human recombinant arginase 1 and uses thereofIMMEDICA PHARMA AB·Filed 2025·Application pending·0 cites
- 0964US2021189371A1Methods For Production Of Human Recombinant Arginase 1 And Uses ThereofAEGLEA BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1061US12144848B2Arginine depletion therapy for treatment of GAMT deficiencyAERASE INC·Filed 2019·Granted Nov 19, 2024·0 cites·35 claims
- 1161US2009155285A1Tgf-beta binding antibodiesJONES BRYAN EDWARD·Filed 2009·Application pending·0 cites
- 1251US2020360493A1Compositions and Methods for Treating Cancer with Arginine Depletion and Immuno Oncology AgentsAEGLEA BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1351US2024058429A1Treatment Of Homocystinuria And Hyperhomocysteinemia Using Cystathionine-Gamma-LyaseAEGLEA BIO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1438US2005054567A1Use of il-19,il-22 and il-24 to treat hematopoietic disordersFiled 2002·Application pending·0 cites
- 1538US2004204351A1Soluble proteins that inhibit cytokine signal transduction pathwaysFiled 2002·Application pending·0 cites
- 1638US2004126777A1Lp mammalian proteins; related reagentsFiled 2002·Application pending·0 cites
- 1737US2004152885A1Lp mammalian proteins; related reagentsFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →